Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Rapid rituximab infusion is safe in paediatric and young adult patients with non-malignant indications.

Literature DB >> 26205134

Rapid rituximab infusion is safe in paediatric and young adult patients with non-malignant indications.

Gregory Wallace¹, Kasiani C Myers¹, Stella M Davies¹, Ashley Teusink², Sonata Jodele³.

Abstract

Entities: Chemical Disease Species

Keywords: anti-CD20 antibody; haematopoietic cell transplant; rapid rituximab infusion; rituximab

Mesh：

Substances：

Year: 2015 PMID： 26205134 PMCID： PMC4724563 DOI： 10.1111/bjh.13604

Source DB: PubMed Journal: Br J Haematol ISSN： 0007-1048 Impact factor: 6.998

× No keyword cloud information.

9 in total

1. Rapid infusion of rituximab over 60 min.

Authors: Mark Tuthill; Tim Crook; Tim Corbet; Jenny King; Andrew Webb
Journal: Eur J Haematol Date: 2009-01-29 Impact factor: 2.997

Review 2. Safety of rapid rituximab infusion in adult cancer patients: a systematic review.

Authors: Dora S P Lang; Christina Hagger; Alan Pearson
Journal: Int J Nurs Pract Date: 2011-08 Impact factor: 2.066

3. Rapid infusion rituximab in combination with corticosteroid-containing chemotherapy or as maintenance therapy is well tolerated and can safely be delivered in the community setting.

Authors: Laurie H Sehn; Jane Donaldson; Allison Filewich; Catherine Fitzgerald; Karamjit K Gill; Nancy Runzer; Barb Searle; Sheila Souliere; John J Spinelli; Judy Sutherland; Joseph M Connors
Journal: Blood Date: 2007-01-23 Impact factor: 22.113

4. Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients.

Authors: Mehdi Khellaf; Anaïs Charles-Nelson; Olivier Fain; Louis Terriou; Jean-François Viallard; Stéphane Cheze; Julie Graveleau; Borhane Slama; Sylvain Audia; Mikael Ebbo; Guillaume Le Guenno; Manuel Cliquennois; Gilles Salles; Caroline Bonmati; France Teillet; Lionel Galicier; Arnaud Hot; Olivier Lambotte; François Lefrère; Salimatou Sacko; Dieudonné Kilendo Kengue; Philippe Bierling; Françoise Roudot-Thoraval; Marc Michel; Bertrand Godeau
Journal: Blood Date: 2014-10-07 Impact factor: 22.113

5. Successful treatment of thrombotic microangiopathy after haematopoietic stem cell transplantation with rituximab.

Authors: Wing-Yan Au; Edmond S Ma; Tsz-Leung Lee; Shau-Yin Ha; Alvin T Fung; Albert K W Lie; Yok-Lam Kwong
Journal: Br J Haematol Date: 2007-04-13 Impact factor: 6.998

6. Rapid infusion rituximab changing practice for patient care.

Authors: Ali Al Zahrani; Nagwa Ibrahim; Ahmed Al Eid
Journal: J Oncol Pharm Pract Date: 2009-01-26 Impact factor: 1.809

7. Safety, efficacy, and immune reconstitution after rituximab therapy in pediatric patients with chronic or refractory hematologic autoimmune cytopenias.

Authors: Aarati Rao; Michael Kelly; Mark Musselman; Jagadeesh Ramadas; David Wilson; William Grossman; Shalini Shenoy
Journal: Pediatr Blood Cancer Date: 2008-04 Impact factor: 3.167

8. Rituximab for steroid-refractory chronic graft-versus-host disease.

Authors: Corey Cutler; David Miklos; Haesook T Kim; Nathaniel Treister; Sook-Bin Woo; Don Bienfang; Lloyd B Klickstein; Jesse Levin; Katherine Miller; Carol Reynolds; Rebecca Macdonell; Mildred Pasek; Stephanie J Lee; Vincent Ho; Robert Soiffer; Joseph H Antin; Jerome Ritz; Edwin Alyea
Journal: Blood Date: 2006-03-21 Impact factor: 22.113

9. Use of a pharmacy protocol to convert standard rituximab infusions to rapid infusion shortens outpatient infusion clinic visits.

Authors: Joshua T Swan; Hanna A Zaghloul; James E Cox; Jose R Murillo
Journal: Pharmacotherapy Date: 2014-04-07 Impact factor: 4.705